InsidersTradesSigma
Follow the Vertex Pharmaceuticals Incorporated stock price and the full insider trade history of the company, a listed equity based in United States. Shares are listed on the US market, under the authority of SEC (Form 4). The latest transaction was reported on 27 August 2026 (Notice of proposed sale (Form 144)). Among the most active insiders: Bruce I. Sachs. The full history is openly available.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
1 of 1 declaration
Vertex Pharmaceuticals Incorporated is a biopharmaceutical company focused on developing treatments for serious diseases, including cystic fibrosis. It is listed on the NASDAQ under the ticker symbol VRTX.